GameChangers: Colchicine Use Post-MI
GameChangers: Colchicine Use Post-MI
In this week’s GameChangers we explore the emerging role of colchicine in the secondary prevention of cardiovascular disease. Drs. Wall and Boyd discuss colchicine’s anti-inflammatory benefits, the challenges posed by side effects and drug interactions, and the latest research shaping its future in clinical practice.
GameChanger: Colchicine shows potential for secondary prevention in cardiovascular disease due to its anti-inflammatory properties, but its clinical use is limited by gastrointestinal side effects and drug interactions.
Upon successful completion of this course, learners should be able to:
1. Identify the potential benefits of colchicine in secondary prevention of cardiovascular disease based on its anti-inflammatory properties.
2. Discuss the limitations of colchicine use in clinical practice, including gastrointestinal side effects and drug interactions.
Geoffrey C. Wall, PharmD, FCCP, BCPS, CG
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences
Mathew Boyd, PharmD
Clinical Pharmacist, Unity Point
Dr. Wall is a member of the Janssen Speaker’s Bureau. All relevant financial relationships have been mitigated.
Matthew Boyd has no relevant financial relationships to disclose.
Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: June 17, 2024
Planned Expiration Date: June 17, 2025
Copyright 2024, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.
CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.
¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.
Additional information
Duration | 0h 30m |
---|---|
Topic Designator | Disease State/Drug Therapy |
ACPE | Yes |
ACPE Topic | 01 Drug Therapy |
Role | Pharmacist |
Media-Type | Podcast |
Release Date | 6/17/24 |
CEUs | 0.05 |
Rating | 4 |
ACPE Number | 0107-0000-24-190-H01-P |
This course is in our subscription.
Related products
-
-
-
Applying Guideline-Based Treatment for Patients with Renal Cell Carcinoma
In Courses, PharmacistRated 0 out of 5$24.00